A study conducted by Alò and collaborators demonstrated that FASN overexpression is associated with the stage of progression of breast cancer and that FASN expression can be used as a prognostic indicator for disease-free survival and overall disease survival [76]. The gene discussed is FASN; the disease is breast cancer.